Current status and residual risks of the patients with atherosclerotic cardiovascular disease in Taiwan - Data from the T-SPARCLE Study

Yu Chung Hsiao; Fang Ju Lin; Wei Hsian Yin; Hung I. Yeh; Jaw Wen Chen; Chau Chung Wu

doi:10.6890/IJGE.202107_15(3).0019

Current status and residual risks of the patients with atherosclerotic cardiovascular disease in Taiwan - Data from the T-SPARCLE Study

Yu Chung Hsiao, Fang Ju Lin, Wei Hsian Yin, Hung I. Yeh, Jaw Wen Chen, Chau Chung Wu

Research output: Contribution to journal › Article › peer-review

Abstract

Cardiovascular (CV) disease is a leading cause of death worldwide, with unique disease burden in East Asians. However, Asian cohort of CV disease is insufficient. Therefore, a prospective, multicenter observational registry study, Taiwanese Secondary Prevention for patients with AtheRosCLErotic disease (TSPARCLE) Registry, has been run since 2010 to document treatment and outcome of CV disease in Taiwan. We identified several region-specific issues, including treatment patterns, general and residual risk factors, which might be valuable for guiding patient care.

Original language	English
Pages (from-to)	284-285
Number of pages	2
Journal	International Journal of Gerontology
Volume	15
Issue number	3
DOIs	https://doi.org/10.6890/IJGE.202107_15(3).0019
Publication status	Published - Jul 1 2021
Externally published	Yes

Keywords

Blood lipid
Cardiovascular disease
Risk factor
Secondary prevention

ASJC Scopus subject areas

Geriatrics and Gerontology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.6890/IJGE.202107_15(3).0019

Cite this

@article{8487aef8b31144be9677b9dc768668b4,

title = "Current status and residual risks of the patients with atherosclerotic cardiovascular disease in Taiwan - Data from the T-SPARCLE Study",

abstract = "Cardiovascular (CV) disease is a leading cause of death worldwide, with unique disease burden in East Asians. However, Asian cohort of CV disease is insufficient. Therefore, a prospective, multicenter observational registry study, Taiwanese Secondary Prevention for patients with AtheRosCLErotic disease (TSPARCLE) Registry, has been run since 2010 to document treatment and outcome of CV disease in Taiwan. We identified several region-specific issues, including treatment patterns, general and residual risk factors, which might be valuable for guiding patient care.",

keywords = "Blood lipid, Cardiovascular disease, Risk factor, Secondary prevention",

author = "Hsiao, {Yu Chung} and Lin, {Fang Ju} and Yin, {Wei Hsian} and Yeh, {Hung I.} and Chen, {Jaw Wen} and Wu, {Chau Chung}",

note = "Publisher Copyright: {\textcopyright} 2021, Taiwan Society of Geriatric Emergency & Critical Care Medicine.",

year = "2021",

month = jul,

day = "1",

doi = "10.6890/IJGE.202107_15(3).0019",

language = "English",

volume = "15",

pages = "284--285",

journal = "International Journal of Gerontology",

issn = "1873-9598",

publisher = "Elsevier Taiwan LLC",

number = "3",

}

TY - JOUR

T1 - Current status and residual risks of the patients with atherosclerotic cardiovascular disease in Taiwan - Data from the T-SPARCLE Study

AU - Hsiao, Yu Chung

AU - Lin, Fang Ju

AU - Yin, Wei Hsian

AU - Yeh, Hung I.

AU - Chen, Jaw Wen

AU - Wu, Chau Chung

PY - 2021/7/1

Y1 - 2021/7/1

N2 - Cardiovascular (CV) disease is a leading cause of death worldwide, with unique disease burden in East Asians. However, Asian cohort of CV disease is insufficient. Therefore, a prospective, multicenter observational registry study, Taiwanese Secondary Prevention for patients with AtheRosCLErotic disease (TSPARCLE) Registry, has been run since 2010 to document treatment and outcome of CV disease in Taiwan. We identified several region-specific issues, including treatment patterns, general and residual risk factors, which might be valuable for guiding patient care.

AB - Cardiovascular (CV) disease is a leading cause of death worldwide, with unique disease burden in East Asians. However, Asian cohort of CV disease is insufficient. Therefore, a prospective, multicenter observational registry study, Taiwanese Secondary Prevention for patients with AtheRosCLErotic disease (TSPARCLE) Registry, has been run since 2010 to document treatment and outcome of CV disease in Taiwan. We identified several region-specific issues, including treatment patterns, general and residual risk factors, which might be valuable for guiding patient care.

KW - Blood lipid

KW - Cardiovascular disease

KW - Risk factor

KW - Secondary prevention

UR - http://www.scopus.com/inward/record.url?scp=85114425477&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85114425477&partnerID=8YFLogxK

U2 - 10.6890/IJGE.202107_15(3).0019

DO - 10.6890/IJGE.202107_15(3).0019

M3 - Article

AN - SCOPUS:85114425477

SN - 1873-9598

VL - 15

SP - 284

EP - 285

JO - International Journal of Gerontology

JF - International Journal of Gerontology

IS - 3

ER -

Current status and residual risks of the patients with atherosclerotic cardiovascular disease in Taiwan - Data from the T-SPARCLE Study

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this